Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05977907
Title Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN). (KIEO)
Acronym KIEO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sibley Memorial Hospital NOT_YET_RECRUITING Washington District of Columbia 20016 United States Details
Northwestern Memorial Hospital NOT_YET_RECRUITING Chicago Illinois 60611 United States Details
Johns Hopkins University RECRUITING Baltimore Maryland 21287 United States Details
Providence Cancer Institute NOT_YET_RECRUITING Portland Oregon 97213 United States Details
Thomas Jefferson University Hospital NOT_YET_RECRUITING Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field